Deal typeTransaction Services
IndustryLife Sciences
Client nameLGC (Holdings) Limited
LGC has further strengthened its nucleic acid chemistry (NAC) offering with the acquisition of Berry & Associates, a premier supplier of specialty oligo reagents. Its products are sold to customers in the pharmaceutical, clinical diagnostics and academic research sectors as well as to oligonucleotide synthesis companies and contract manufacturing organisations.
LGC Group is an international leader in the extended life sciences sector, including human healthcare, agri-food & the environment.